SK284689B6 - Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom - Google Patents

Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom Download PDF

Info

Publication number
SK284689B6
SK284689B6 SK1197-2000A SK11972000A SK284689B6 SK 284689 B6 SK284689 B6 SK 284689B6 SK 11972000 A SK11972000 A SK 11972000A SK 284689 B6 SK284689 B6 SK 284689B6
Authority
SK
Slovakia
Prior art keywords
benzopyrano
dihydro
trimethyl
quinoline
methoxy
Prior art date
Application number
SK1197-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK11972000A3 (sk
Inventor
Michael J. Coughlan
Steven W. Elmore
Michael E. Kort
Philip R. Kym
Jimmie L. Moore
John K. Pratt
Alan X. Wang
James P. Edwards
Todd K. Jones
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals, Inc. filed Critical Abbott Laboratories
Publication of SK11972000A3 publication Critical patent/SK11972000A3/sk
Publication of SK284689B6 publication Critical patent/SK284689B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SK1197-2000A 1998-02-13 1999-02-12 Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom SK284689B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
SK11972000A3 SK11972000A3 (sk) 2001-08-06
SK284689B6 true SK284689B6 (sk) 2005-09-08

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1197-2000A SK284689B6 (sk) 1998-02-13 1999-02-12 Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom

Country Status (21)

Country Link
EP (1) EP1053239B1 (ko)
JP (1) JP2002503665A (ko)
KR (1) KR20010040935A (ko)
CN (1) CN1119348C (ko)
AT (1) ATE230749T1 (ko)
AU (1) AU766441B2 (ko)
BG (1) BG64317B1 (ko)
BR (1) BR9907788A (ko)
CA (1) CA2320943A1 (ko)
DE (1) DE69904804T2 (ko)
DK (1) DK1053239T3 (ko)
ES (1) ES2192035T3 (ko)
HK (1) HK1033308A1 (ko)
HU (1) HUP0100460A3 (ko)
IL (1) IL137508A0 (ko)
NO (1) NO20004053L (ko)
NZ (1) NZ506013A (ko)
PL (1) PL193323B1 (ko)
SK (1) SK284689B6 (ko)
TR (1) TR200003094T2 (ko)
WO (1) WO1999041256A1 (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
DE60113032T2 (de) 2000-10-30 2006-07-06 Pfizer Products Inc., Groton Glukokortikoidrezeptor-Modulatoren
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
CA2472746A1 (en) 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
WO2003082787A1 (en) 2002-03-26 2003-10-09 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
ES2298508T3 (es) 2002-03-26 2008-05-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
DE60335869D1 (de) 2002-04-11 2011-03-10 Merck Sharp & Dohme 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1532113B1 (en) 2002-08-21 2008-08-06 Boehringer Ingelheim Pharmaceuticals Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1558618A1 (en) 2002-10-11 2005-08-03 Ligand Pharmaceuticals, Inc. 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
EP1551845A1 (en) 2002-10-11 2005-07-13 Ligand Pharmaceuticals, Inc. 5-CYCLOALKENYL 5 i H /i -CHROMENO 3,4-F QUINOLINE DERIV ATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
WO2004063163A1 (en) 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
EP1675839B1 (en) 2003-10-16 2007-07-11 Boehringer Ingelheim Pharmaceuticals Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7741361B2 (en) 2004-12-27 2010-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2621292C (en) * 2005-09-14 2014-05-27 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
JP2012530140A (ja) 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用
WO2011016050A2 (en) 2009-07-31 2011-02-10 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531998T2 (de) * 1994-12-22 2004-07-22 Ligand Pharmaceuticals, Inc., San Diego Steroidrezeptor-modulator verbindungen und methoden

Also Published As

Publication number Publication date
ATE230749T1 (de) 2003-01-15
BG104719A (en) 2001-05-31
BR9907788A (pt) 2001-10-30
PL343018A1 (en) 2001-07-30
IL137508A0 (en) 2001-07-24
JP2002503665A (ja) 2002-02-05
CN1119348C (zh) 2003-08-27
NO20004053L (no) 2000-09-11
SK11972000A3 (sk) 2001-08-06
EP1053239B1 (en) 2003-01-08
HUP0100460A2 (hu) 2001-09-28
CN1296486A (zh) 2001-05-23
HUP0100460A3 (en) 2003-03-28
NZ506013A (en) 2003-03-28
DK1053239T3 (da) 2003-04-22
PL193323B1 (pl) 2007-02-28
BG64317B1 (bg) 2004-09-30
EP1053239A1 (en) 2000-11-22
HK1033308A1 (en) 2001-08-24
AU766441B2 (en) 2003-10-16
DE69904804T2 (de) 2003-11-06
NO20004053D0 (no) 2000-08-11
ES2192035T3 (es) 2003-09-16
CA2320943A1 (en) 1999-09-19
AU2677399A (en) 1999-08-30
TR200003094T2 (tr) 2001-01-22
WO1999041256A1 (en) 1999-08-19
KR20010040935A (ko) 2001-05-15
DE69904804D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
SK284689B6 (sk) Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom
US6951942B2 (en) Glucocorticoid-selective anti-inflammatory agents
DE60305446T4 (de) Desazapurine und deren verwendung
EP2041142B1 (de) Spirocyclische azaindol-derivate
CN111285850A (zh) 一类异吲哚啉类化合物、其制备方法、药物组合物及其应用
JPH08511238A (ja) ▲iv▼型ホスホジエステラーゼ阻害因子としてのキノリン類
TW200808808A (en) Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
CN111032034A (zh) 螺环化合物及其制造和使用方法
CA3046212A1 (en) Heterocyclic inhibitors of mct4
CA3172478A1 (en) Bcl-2 inhibitor
US20230128062A1 (en) Azabicyclic substituted oxaspiro derivative, preparation method therefor and medical use thereof
EP3337800A1 (de) Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamid und dessen aufreinigung für die verwendung als pharmazeutischer wirkstoff
JP2023513373A (ja) P2x3修飾薬
JP2002508359A (ja) 複素環式細胞毒性剤
JP2021512879A (ja) プロブコール誘導体及びその調製方法と使用
KR20000070756A (ko) 동맥경화증 및 지단백질과잉혈증 치료에 사용되는 2-아미노 치환된 피리딘
US11459353B2 (en) Steroids and methods of manufacture
DE10250687A1 (de) 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung
JP5726321B2 (ja) オキサゾロ[5,4−b]ピリジン−5−イル化合物および癌治療へのその使用
CZ20002893A3 (cs) Glukokortikoidně selektivní protizánětlivé látky
CA2362272A1 (en) Spirocyclic ketones and their use as tachykinin antagonists
MXPA00007944A (en) Glucocorticoid-selective anti-inflammatory agents
RU2800296C1 (ru) Оксаспиро-производное, замещенное по азабициклическому кольцу, способ его получения и его медицинское применение
CN113831346B (zh) 多靶点抗肿瘤小分子及其衍生物、制法、药物组合物和应用
NO309506B1 (no) Anxiolytisk middel, bisyklolaktamforbindelse og anvendelse av nye og kjente bisyklolaktamforbindelser